分子合作伙伴报告第一季度业绩

2025-05-16 17:43

Molecular Partners AG press release (OTCPK:MLLCF): Q1 GAAP EPS of -CHF 0.45.
For the full year 2025, at constant exchange rates, the company expects total operating expenses of CHF 55M-65M of which around CHF 7M will be non-cash effective costs for share-based payments, IFRS pension accounting and depreciation.
The company's cash and cash equivalents and short-term time deposits were CHF 131M as of March 31, 2025 and based on current operating assumptions, will be sufficient to fund its operating expenses and capital expenditure requirements well into 2027.

More on Molecular Partners